B M Moore
Overview
Explore the profile of B M Moore including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
347
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hager T, Moore B, Borengasser Q, Kanaherarachchi A, Renshaw K, Radhakrishnan S, et al.
J Chem Phys
. 2024 Sep;
161(9).
PMID: 39225516
This second paper in a series of two describes the chirped-pulse ice apparatus that permits the detection of buffer gas cooled molecules desorbed from an energetically processed ice using broadband...
2.
Pressly J, Soni H, Jiang S, Wei J, Liu R, Moore B, et al.
Physiol Genomics
. 2019 Feb;
51(3):90-96.
PMID: 30707046
Acute kidney injury (AKI) is an increasing clinical problem that is associated with chronic kidney disease progression. Cannabinoid receptor 2 (CB2) activation has been shown to mitigate some of the...
3.
Willey J, Bennett R, Williams J, Denne R, Kornegay C, Perlotto M, et al.
Environ Sci Technol
. 2011 Dec;
22(1):41-6.
PMID: 22195508
No abstract available.
4.
Moore B, Alex-Hart B, George I
East Afr J Public Health
. 2011 Nov;
8(1):49-51.
PMID: 22066284
Objective: Poor utilization of health facilities during delivery by pregnant mothers is still a major cause of maternal and childhood morbidity and mortality in Nigeria. The aim of this study...
5.
Lentz B, Moore B, Kirkman C, Meissner G
Biophys J
. 2009 May;
37(1):30-2.
PMID: 19431485
No abstract available.
6.
Greenberg C, Hursting M, Macik B, Ortel T, Kane W, Moore B
Clin Chem
. 1994 Oct;
40(10):1962-9.
PMID: 7923780
We have used a monoclonal antibody-based ELISA for plasma prothrombin fragment 1.2 (F1.2) to establish appropriate sample collection and storage conditions for this biomarker of thrombin generation. F1.2 concentrations were...
7.
Hursting M, Stead A, Crout F, Horvath B, Moore B
Clin Chem
. 1993 Apr;
39(4):683-6.
PMID: 8472366
Prothrombin fragment 1.2 (F1.2) is a biomarker of thrombin generation during blood coagulation and has diagnostic potential for assessing thrombotic risk and monitoring anticoagulation therapy. We used a monoclonal antibody-based...
8.
Hursting M, Butman B, Steiner J, Moore B, Plank M, Szewczyk K, et al.
Clin Chem
. 1993 Apr;
39(4):583-91.
PMID: 7682482
Prothrombin fragment 1.2 (F1.2) is an activation peptide generated during a critical event of blood coagulation, the conversion of prothrombin to thrombin. As a marker of thrombin generation, F1.2 has...
9.
Moore B, Flurkey W
J Biol Chem
. 1990 Mar;
265(9):4982-8.
PMID: 2108164
Latent broad bean polyphenoloxidase was purified and shown to be activated by sodium dodecyl sulfate (SDS). Further characterization of the enzyme was carried out in the presence and absence of...
10.
Moore B, Kang B, Flurkey W
Histochemistry
. 1989 Jan;
90(5):379-81.
PMID: 2497092
Mushrooms were cut into vertical and horizontal sections. These sections were blotted onto nitrocellulose sheets and the sheets were then stained for tyrosinase using L-dopa. Tyrosinase was localized throughout the...